Varex Imaging (NASDAQ:VREX) Raised to Strong-Buy at Wall Street Zen

Varex Imaging (NASDAQ:VREX) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a report issued on Saturday.

A number of other equities research analysts have also issued reports on VREX. Weiss Ratings reissued a “sell (d)” rating on shares of Varex Imaging in a research report on Wednesday, October 8th. B. Riley reiterated a “buy” rating and issued a $16.00 price objective on shares of Varex Imaging in a report on Wednesday, November 19th. Finally, Oppenheimer reduced their target price on shares of Varex Imaging from $23.00 to $18.00 and set an “outperform” rating for the company in a report on Wednesday, November 19th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, Varex Imaging presently has a consensus rating of “Hold” and an average price target of $17.00.

Varex Imaging Trading Up 3.7%

VREX opened at $10.67 on Friday. The stock has a market capitalization of $444.94 million, a P/E ratio of -6.28 and a beta of 0.98. The company has a current ratio of 3.43, a quick ratio of 1.83 and a debt-to-equity ratio of 0.75. Varex Imaging has a 12 month low of $6.76 and a 12 month high of $16.93. The firm’s fifty day simple moving average is $11.78 and its 200 day simple moving average is $9.88.

Varex Imaging (NASDAQ:VREX) last released its earnings results on Tuesday, November 18th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.18 by $0.19. The firm had revenue of $228.90 million during the quarter, compared to analysts’ expectations of $219.26 million. Varex Imaging had a positive return on equity of 7.19% and a negative net margin of 8.32%. Varex Imaging has set its Q1 2026 guidance at 0.050-0.250 EPS. As a group, research analysts anticipate that Varex Imaging will post 0.53 EPS for the current fiscal year.

Institutional Trading of Varex Imaging

Several institutional investors and hedge funds have recently added to or reduced their stakes in VREX. The Manufacturers Life Insurance Company lifted its stake in Varex Imaging by 10.4% in the second quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock valued at $133,000 after acquiring an additional 1,442 shares during the last quarter. LSV Asset Management raised its holdings in shares of Varex Imaging by 0.5% in the 2nd quarter. LSV Asset Management now owns 328,610 shares of the company’s stock valued at $2,849,000 after purchasing an additional 1,631 shares during the period. Comerica Bank lifted its stake in Varex Imaging by 9.3% in the 3rd quarter. Comerica Bank now owns 20,363 shares of the company’s stock valued at $253,000 after purchasing an additional 1,726 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in Varex Imaging by 18.5% during the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock worth $113,000 after purchasing an additional 2,036 shares during the period. Finally, State of Alaska Department of Revenue bought a new position in Varex Imaging during the third quarter worth about $27,000.

About Varex Imaging

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.